06.01.17

Alcon’s ORA System with VerifEye Technology Now Available in Canada

Source: Alcon

Alcon Canada, a division of Alcon, announced that the Valley Laser Eye Centre, in Abbotsford, BC, recently became the first facility in Canada to offer the ORA System with VerifEye technology to patients requiring cataract surgery.

The ORA System with VerifEye technology is an intraoperative aberrometer that provides real-time, reliable data and image guidance to ophthalmologists, so they can more accurately select the appropriate advanced intraocular lens (ATIOL) power and placement during cataract surgery.

The ORA System with VerifEye technology is a powerful tool for surgeons in helping to improve postoperative visual outcomes, even with patients who have previously undergone laser vision correction or photorefractive keratectomy surgery, said John Blaylock, MD FRCSC, of the Valley Laser Eye Center.

"ORA intraoperative aberrometry is the most significant technical advancement in cataract surgery and refractive lensectomy since laser-assisted cataract surgery," Dr. Blaylock, who led a discussion earlier this month on intraoperative aberrometry at the B.C. Society of Eye Physicians and Surgeons' Annual meeting, said in a company news release.

According to one study, the ORA System with VerifEye technology lowered the number of patients who fell outside of their intended astigmatic target by almost 54%.

The system has also proven effective in more challenging cases, such as patients who have previously undergone laser vision correction, with a related study finding that among those patients who had previously undergone laser vision correction surgery, 45% more were able to reach their intended refractive target when surgeons performed cataract surgery with the aid of the ORA system than without it.

"The ORA System with VerifEye Technology acts as an 'insurance policy'," Brian Chan, Sr. Product Manager, CORE Cataract and Refractive Lasers at Alcon Canada, said in a news release. "It allows surgeons to verify their measurements and identify any refractive issues throughout a surgery, including during those crucial moments after they've removed the natural lens of a patient that's been impacted by cataracts."

Whether or not a surgeon uses the ORA System with VerifEye technology can pose other significant quality of life implications for patients. "It can mean the difference between needing to wear glasses after cataract surgery or not," Mr. Chan said.

In addition to its accuracy, the system's robust software, which supports Alcon's entire cataract refractive suite, can perform post-op analysis on refractive outcomes and enable surgeons to compare their results with those of their colleagues around the globe.

"The precision of the ORA not only takes the guesswork out of predicting refractive outcomes, but it significantly reduces the need to explant and replace lenses, which benefits my practice and, most importantly, my patients," Dr. Blaylock said.

 

Related Content